During the last session, Equillium Inc (NASDAQ:EQ)’s traded shares were 73207.0, with the beta value of the company hitting 1.94. At the end of the trading day, the stock’s price was $0.47, reflecting an intraday gain of 8.02% or $0.03. The 52-week high for the EQ share is $1.89, that puts it down -302.13 from that peak though still a striking 23.4% gain since the share price plummeted to a 52-week low of $0.36. The company’s market capitalization is $16.83M, and the average intraday trading volume over the past 10 days was 83180.0 shares, and the average trade volume was 800.68K shares over the past three months.
Equillium Inc (EQ) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 3.00. EQ has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.26.
Equillium Inc (NASDAQ:EQ) trade information
Equillium Inc (EQ) registered a 8.02% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 8.02% in intraday trading to $0.47, hitting a weekly high. The stock’s 5-day price performance is 3.62%, and it has moved by -41.65% in 30 days. Based on these gigs, the overall price performance for the year is -74.46%. The short interest in Equillium Inc (NASDAQ:EQ) is 0.28 million shares and it means that shorts have 2.08 day(s) to cover.
The consensus price target of analysts on Wall Street is $1, which implies an increase of 53.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $1 and $1 respectively. As a result, EQ is trading at a discount of -112.77% off the target high and -112.77% off the low.
Equillium Inc (EQ) estimates and forecasts
In the rating firms’ projections, revenue will decrease -100.00% compared to the previous financial year.
As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 10.69M and 13.85M respectively. In this case, analysts expect current quarter sales to shrink by -100.00% and then drop by -100.00% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 31.13%. While earnings are projected to return -234.78% in 2025.
EQ Dividends
Equillium Inc is due to release its next quarterly earnings on 2025-Mar-26. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Equillium Inc (NASDAQ:EQ)’s Major holders
Equillium Inc insiders own 35.86% of total outstanding shares while institutional holders control 19.30%, with the float percentage being 30.09%. DECHENG CAPITAL LLC is the largest shareholder of the company, while 27.0 institutions own stock in it. As of 2024-06-30, the company held over 4.45 million shares (or 12.6148% of all shares), a total value of $3.08 million in shares.
The next largest institutional holding, with 1.82 million shares, is of TAKEDA PHARMACEUTICAL CO LTD’s that is approximately 5.1711% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.26 million.
